Strides Arcolab: Taking long strides – BUY Report By IIFL
CMP Rs1,180, Target Rs1,500, Upside 27.1%
In its second coming, Strides Arcolab is well on its way to rebuilding robust scalable operations across key geographies after successful monetization of injectables business. The company has moved up the value chain in emerging and regulated markets (31% of FY16E revenues) through creation of owned front end and localized manufacturing facilities (in Africa). US business is…
Strides Arcolab: Taking long strides – BUY Report By IIFL
Subscribe To Our Free Newsletter |